Amerikanische Gesellschaft für Hirudotherapie

Comparisons of medicinal leech therapy with venous catheterization in the treatment of venous congestion of the sural flap

Randomized controlled trial published in Microsurgery (2010)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Randomized controlled trialKlinische StudienMozafari N et al. · Microsurgery, 2010

Abstract

INTRODUCTION: The originally described distally based sural flap technique has a risk of partial or total flap necrosis as high as 25%. The purpose of this study was to compare the medicinal leech therapy (MLT) with venous catheterization (VC) for blood volume removal, infection, wound dehiscence, and flap necrosis in the distally based sural flap with venous congestion. PATIENTS AND METHODS: Fifty-six conventional distally based sural flaps with venous congestion during reconstructive surgeries were randomly divided into two groups, MLT group and VC group. The results of comparisons were analyzed using SPSS software (SPSS for Windows Ver.11.5). RESULTS: There were significant differences in terms of the average volume of removed blood (53.6cc vs.172.2cc), infection (10.7% vs. 34.6%), wound dehiscence (10.7% vs. 42.3%), flap necrosis (3.6% vs. 19.2%), and nursing (7.8 vs. 5.19) and patient's satisfaction (8.03 vs. 5.6) in the VC group and MLT group, respectively. Although local heparin irrigation was performed in the VC group, the catheter was exchanged in 10 patients due to obstruction by clot. CONCLUSION: It is recommended that the VC be used for congested pedicled flaps instead of leech therapy, as VC is more effective, easy, and safe in blood removal, and it has less complication.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal ArticleRandomized Controlled Trial
Indexed MeSH termsAdolescentAdultCatheterization, PeripheralFemaleFree Tissue FlapsHumansHyperemiaLeechingMaleMiddle AgedNecrosisPatient Satisfaction

Zusammenfassung

RCT of 56 sural flaps with venous congestion comparing medicinal leech therapy versus venous catheterization. VC group showed less infection (10.7% vs 34.6%), wound dehiscence (10.7% vs 42.3%), and flap necrosis (3.6% vs 19.2%).

Warum dies für die Hirudotherapie relevant ist

This randomized controlled trial compared medicinal leech therapy (MLT) with venous catheterization (VC) in 56 distally based sural flaps with venous congestion, evaluating removed blood volume, infection, wound dehiscence, and flap necrosis. The abstract reports that average removed blood volume was 53.6 cc in the VC group versus 172.2 cc in the MLT group, with higher rates of infection (34.6% vs. 10.7%), wound dehiscence (42.3% vs. 10.7%), and flap necrosis (19.2% vs. 3.6%) in the MLT group, leading the authors to recommend VC over leech therapy for congested pedicled flaps. For ASH's domain, this provides direct comparative efficacy and complication data for hirudotherapy. Caveat: Findings favor the comparator rather than leech therapy in this specific flap context, and generalizability to other hirudotherapy applications is limited.

Zitation

Comparisons of medicinal leech therapy with venous catheterization in the treatment of venous congestion of the sural flap.

Mozafari N et al. · Microsurgery, 2010

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.